Wasatch Advisors Inc Intra Cellular Therapies, Inc. Transaction History

Wasatch Advisors Inc

  • $18.5 Billion
  • Q2 2024

A detailed history of Wasatch Advisors Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 3,718,237 shares of ITCI stock, worth $273 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
3,718,237
Previous 3,854,747 3.54%
Holding current value
$273 Million
Previous $267 Million 4.53%
% of portfolio
1.37%
Previous 1.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $8.84 Million - $10.9 Million
-136,510 Reduced 3.54%
3,718,237 $255 Million
Q1 2024

Apr 18, 2024
BUY
$64.37 - $75.65 $14.6 Million - $17.2 Million
227,439 Added 6.27%
3,854,747 $267 Million
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $8.15 Million - $12.9 Million
-175,831 Reduced 4.62%
3,627,308 $260 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $16.6 Million - $20.4 Million
318,120 Added 9.13%
3,803,139 $198 Million
Q2 2023

Aug 07, 2023
SELL
$54.67 - $66.44 $54.4 Million - $66.1 Million
-994,557 Reduced 22.2%
3,485,019 $221 Million
Q1 2023

May 12, 2023
SELL
$43.8 - $56.99 $11.4 Million - $14.8 Million
-260,569 Reduced 5.5%
4,479,576 $243 Million
Q4 2022

Feb 14, 2023
SELL
$44.07 - $54.45 $22.2 Million - $27.4 Million
-503,145 Reduced 9.6%
4,740,145 $251 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $6.31 Million - $8.87 Million
-147,775 Reduced 2.74%
5,243,290 $244 Million
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $89.7 Million - $137 Million
-2,086,803 Reduced 27.91%
5,391,065 $308 Million
Q1 2022

May 13, 2022
SELL
$38.74 - $62.09 $29.3 Million - $47 Million
-757,303 Reduced 9.2%
7,477,868 $458 Million
Q4 2021

Feb 15, 2022
BUY
$35.2 - $53.42 $3.95 Million - $5.99 Million
112,167 Added 1.38%
8,235,171 $431 Million
Q3 2021

Nov 12, 2021
BUY
$28.72 - $42.49 $46.4 Million - $68.7 Million
1,616,215 Added 24.84%
8,123,004 $303 Million
Q2 2021

Aug 12, 2021
SELL
$29.3 - $44.5 $543,046 - $824,763
-18,534 Reduced 0.28%
6,506,789 $266 Million
Q1 2021

May 10, 2021
BUY
$30.8 - $39.51 $5.9 Million - $7.56 Million
191,423 Added 3.02%
6,525,323 $221 Million
Q4 2020

Feb 12, 2021
BUY
$23.34 - $32.22 $21.6 Million - $29.8 Million
925,021 Added 17.1%
6,333,900 $201 Million
Q3 2020

Nov 10, 2020
BUY
$17.61 - $31.86 $30.8 Million - $55.7 Million
1,748,285 Added 47.76%
5,408,879 $139 Million
Q2 2020

Aug 12, 2020
BUY
$14.35 - $26.64 $10.5 Million - $19.4 Million
728,329 Added 24.84%
3,660,594 $94 Million
Q1 2020

May 08, 2020
BUY
$12.31 - $33.12 $14.2 Million - $38.1 Million
1,150,566 Added 64.58%
2,932,265 $45.1 Million
Q4 2019

Feb 13, 2020
SELL
$7.26 - $38.49 $16.2 Million - $86 Million
-2,234,061 Reduced 55.63%
1,781,699 $61.1 Million
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $12.5 Million - $23.4 Million
1,667,728 Added 71.03%
4,015,760 $30 Million
Q2 2019

Aug 07, 2019
SELL
$10.65 - $14.29 $144,701 - $194,158
-13,587 Reduced 0.58%
2,348,032 $0
Q1 2019

May 08, 2019
BUY
$10.9 - $14.09 $4.12 Million - $5.32 Million
377,561 Added 19.03%
2,361,619 $0
Q4 2018

Feb 14, 2019
BUY
$10.36 - $20.96 $580,574 - $1.17 Million
56,040 Added 2.91%
1,984,058 $22.6 Million
Q3 2018

Nov 07, 2018
BUY
$17.77 - $22.9 $351,614 - $453,122
19,787 Added 1.04%
1,928,018 $0
Q2 2018

Aug 02, 2018
BUY
$17.33 - $23.4 $448,656 - $605,802
25,889 Added 1.38%
1,908,231 $0
Q1 2018

May 02, 2018
SELL
$15.16 - $25.49 $645,437 - $1.09 Million
-42,575 Reduced 2.21%
1,882,342 $0
Q4 2017

Jan 16, 2018
SELL
$14.27 - $16.79 $645,917 - $759,982
-45,264 Reduced 2.3%
1,924,917 $0
Q3 2017

Nov 08, 2017
BUY
$10.77 - $22.1 $3.35 Million - $6.87 Million
310,668 Added 18.72%
1,970,181 $0
Q2 2017

Aug 16, 2017
BUY
N/A
1,659,513
1,659,513 $0

Others Institutions Holding ITCI

# of Institutions
400
Shares Held
87.2M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email